nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—UGT2B7—Chenodeoxycholic acid—primary biliary cirrhosis	0.597	0.92	CbGbCtD
Dabigatran etexilate—ABCB1—Colchicine—primary biliary cirrhosis	0.0517	0.0798	CbGbCtD
Dabigatran etexilate—F2—portal vein—primary biliary cirrhosis	0.0336	0.439	CbGeAlD
Dabigatran etexilate—UGT2B15—gall bladder—primary biliary cirrhosis	0.0105	0.138	CbGeAlD
Dabigatran etexilate—CES2—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00781	0.0874	CbGpPWpGaD
Dabigatran etexilate—CES2—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00664	0.0743	CbGpPWpGaD
Dabigatran etexilate—F2—gall bladder—primary biliary cirrhosis	0.00578	0.0754	CbGeAlD
Dabigatran etexilate—CES1—gall bladder—primary biliary cirrhosis	0.0053	0.0692	CbGeAlD
Dabigatran etexilate—CES1—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.0046	0.0515	CbGpPWpGaD
Dabigatran etexilate—Drug hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.0045	0.0243	CcSEcCtD
Dabigatran etexilate—Drug hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.0045	0.0243	CcSEcCtD
Dabigatran etexilate—UGT2B7—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00414	0.0463	CbGpPWpGaD
Dabigatran etexilate—CES1—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00391	0.0438	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00369	0.0413	CbGpPWpGaD
Dabigatran etexilate—CES2—Fluoropyrimidine Activity—ABCG2—primary biliary cirrhosis	0.00334	0.0374	CbGpPWpGaD
Dabigatran etexilate—CES2—smooth muscle tissue—primary biliary cirrhosis	0.00321	0.0419	CbGeAlD
Dabigatran etexilate—UGT2B15—liver—primary biliary cirrhosis	0.00309	0.0404	CbGeAlD
Dabigatran etexilate—F2—epithelium—primary biliary cirrhosis	0.00299	0.039	CbGeAlD
Dabigatran etexilate—Transaminases increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00298	0.0161	CcSEcCtD
Dabigatran etexilate—Transaminases increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00298	0.0161	CcSEcCtD
Dabigatran etexilate—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.0028	0.0313	CbGpPWpGaD
Dabigatran etexilate—Thrombosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.0138	CcSEcCtD
Dabigatran etexilate—Thrombosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.0138	CcSEcCtD
Dabigatran etexilate—UGT1A9—liver—primary biliary cirrhosis	0.00234	0.0306	CbGeAlD
Dabigatran etexilate—Gout—Colchicine—primary biliary cirrhosis	0.00216	0.0116	CcSEcCtD
Dabigatran etexilate—UGT1A9—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00215	0.024	CbGpPWpGaD
Dabigatran etexilate—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.0108	CcSEcCtD
Dabigatran etexilate—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.0108	CcSEcCtD
Dabigatran etexilate—CES1—Fluoropyrimidine Activity—ABCG2—primary biliary cirrhosis	0.00197	0.0221	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of IGF Activity by IGFBP—IGFBP1—primary biliary cirrhosis	0.00195	0.0219	CbGpPWpGaD
Dabigatran etexilate—Hepatic enzyme increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.0103	CcSEcCtD
Dabigatran etexilate—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.0103	CcSEcCtD
Dabigatran etexilate—Hepatic enzyme increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.0103	CcSEcCtD
Dabigatran etexilate—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.0103	CcSEcCtD
Dabigatran etexilate—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00191	0.0214	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—liver—primary biliary cirrhosis	0.00189	0.0246	CbGeAlD
Dabigatran etexilate—CES2—liver—primary biliary cirrhosis	0.00189	0.0246	CbGeAlD
Dabigatran etexilate—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00989	CcSEcCtD
Dabigatran etexilate—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00989	CcSEcCtD
Dabigatran etexilate—UGT1A9—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00183	0.0204	CbGpPWpGaD
Dabigatran etexilate—F2—liver—primary biliary cirrhosis	0.00169	0.0221	CbGeAlD
Dabigatran etexilate—NQO2—liver—primary biliary cirrhosis	0.00169	0.022	CbGeAlD
Dabigatran etexilate—Hepatic function abnormal—Colchicine—primary biliary cirrhosis	0.00168	0.00903	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00893	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00893	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00884	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00884	CcSEcCtD
Dabigatran etexilate—CES1—liver—primary biliary cirrhosis	0.00156	0.0203	CbGeAlD
Dabigatran etexilate—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00154	0.0173	CbGpPWpGaD
Dabigatran etexilate—Hepatic function abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00812	CcSEcCtD
Dabigatran etexilate—Hepatic function abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00812	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00147	0.0079	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00782	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00782	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00727	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00727	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00132	0.00711	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00709	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00709	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00129	0.00696	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00655	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00655	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00121	0.00654	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00648	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00648	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.0012	0.0134	CbGpPWpGaD
Dabigatran etexilate—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00639	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00639	CcSEcCtD
Dabigatran etexilate—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00628	CcSEcCtD
Dabigatran etexilate—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00628	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00626	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00626	CcSEcCtD
Dabigatran etexilate—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00613	CcSEcCtD
Dabigatran etexilate—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00613	CcSEcCtD
Dabigatran etexilate—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00613	CcSEcCtD
Dabigatran etexilate—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00613	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00597	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00597	CcSEcCtD
Dabigatran etexilate—UGT1A9—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00111	0.0124	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.0011	0.0123	CbGpPWpGaD
Dabigatran etexilate—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.0059	CcSEcCtD
Dabigatran etexilate—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.0059	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00588	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00588	CcSEcCtD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—IGFBP1—primary biliary cirrhosis	0.00108	0.0121	CbGpPWpGaD
Dabigatran etexilate—Haematuria—Colchicine—primary biliary cirrhosis	0.00108	0.0058	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00106	0.0057	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00106	0.0057	CcSEcCtD
Dabigatran etexilate—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.0055	CcSEcCtD
Dabigatran etexilate—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.0055	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00547	CcSEcCtD
Dabigatran etexilate—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00547	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00547	CcSEcCtD
Dabigatran etexilate—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00547	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.001	0.00539	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.001	0.00539	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000995	0.00536	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000995	0.00536	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000987	0.00531	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000987	0.00531	CcSEcCtD
Dabigatran etexilate—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000968	0.00521	CcSEcCtD
Dabigatran etexilate—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000968	0.00521	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00096	0.00517	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00096	0.00517	CcSEcCtD
Dabigatran etexilate—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000957	0.00516	CcSEcCtD
Dabigatran etexilate—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000957	0.00516	CcSEcCtD
Dabigatran etexilate—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000952	0.00513	CcSEcCtD
Dabigatran etexilate—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000952	0.00513	CcSEcCtD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.00093	0.0104	CbGpPWpGaD
Dabigatran etexilate—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000916	0.00493	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000916	0.00493	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000914	0.00492	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000911	0.00491	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000911	0.00491	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0009	0.00485	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0009	0.00485	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00483	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00483	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00482	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00482	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000893	0.00481	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000893	0.00481	CcSEcCtD
Dabigatran etexilate—Malnutrition—Colchicine—primary biliary cirrhosis	0.000883	0.00476	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000846	0.00455	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000846	0.00455	CcSEcCtD
Dabigatran etexilate—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000844	0.00944	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000832	0.00932	CbGpPWpGaD
Dabigatran etexilate—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000827	0.00445	CcSEcCtD
Dabigatran etexilate—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000827	0.00445	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000823	0.00443	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000823	0.00443	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000821	0.00442	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000821	0.00442	CcSEcCtD
Dabigatran etexilate—Anaemia—Colchicine—primary biliary cirrhosis	0.000816	0.0044	CcSEcCtD
Dabigatran etexilate—Angioedema—Colchicine—primary biliary cirrhosis	0.000807	0.00434	CcSEcCtD
Dabigatran etexilate—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000793	0.00427	CcSEcCtD
Dabigatran etexilate—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000793	0.00427	CcSEcCtD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.000791	0.00886	CbGpPWpGaD
Dabigatran etexilate—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000782	0.00421	CcSEcCtD
Dabigatran etexilate—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000782	0.00421	CcSEcCtD
Dabigatran etexilate—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000767	0.00413	CcSEcCtD
Dabigatran etexilate—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000767	0.00413	CcSEcCtD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—CCL5—primary biliary cirrhosis	0.000756	0.00847	CbGpPWpGaD
Dabigatran etexilate—Arthralgia—Colchicine—primary biliary cirrhosis	0.000752	0.00405	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000747	0.00836	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000737	0.00825	CbGpPWpGaD
Dabigatran etexilate—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000733	0.00395	CcSEcCtD
Dabigatran etexilate—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000733	0.00395	CcSEcCtD
Dabigatran etexilate—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000725	0.0039	CcSEcCtD
Dabigatran etexilate—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000725	0.0039	CcSEcCtD
Dabigatran etexilate—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000711	0.00383	CcSEcCtD
Dabigatran etexilate—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000711	0.00383	CcSEcCtD
Dabigatran etexilate—Shock—Colchicine—primary biliary cirrhosis	0.000709	0.00382	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000707	0.00381	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000705	0.0038	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000705	0.00789	CbGpPWpGaD
Dabigatran etexilate—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000701	0.00378	CcSEcCtD
Dabigatran etexilate—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000701	0.00378	CcSEcCtD
Dabigatran etexilate—Skin disorder—Colchicine—primary biliary cirrhosis	0.0007	0.00377	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00376	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00376	CcSEcCtD
Dabigatran etexilate—F2—Regulation of IGF Activity by IGFBP—MMP2—primary biliary cirrhosis	0.000695	0.00777	CbGpPWpGaD
Dabigatran etexilate—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000692	0.00373	CcSEcCtD
Dabigatran etexilate—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000692	0.00373	CcSEcCtD
Dabigatran etexilate—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000685	0.00369	CcSEcCtD
Dabigatran etexilate—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000685	0.00369	CcSEcCtD
Dabigatran etexilate—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00364	CcSEcCtD
Dabigatran etexilate—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00364	CcSEcCtD
Dabigatran etexilate—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00364	CcSEcCtD
Dabigatran etexilate—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00364	CcSEcCtD
Dabigatran etexilate—Hypotension—Colchicine—primary biliary cirrhosis	0.000673	0.00363	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000671	0.00361	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000671	0.00361	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000656	0.00354	CcSEcCtD
Dabigatran etexilate—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000643	0.00346	CcSEcCtD
Dabigatran etexilate—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000643	0.00346	CcSEcCtD
Dabigatran etexilate—ABCB1—epithelium—primary biliary cirrhosis	0.000643	0.00839	CbGeAlD
Dabigatran etexilate—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000637	0.00343	CcSEcCtD
Dabigatran etexilate—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000637	0.00343	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000635	0.00342	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000635	0.00342	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000634	0.00341	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000634	0.00341	CcSEcCtD
Dabigatran etexilate—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000629	0.00339	CcSEcCtD
Dabigatran etexilate—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000629	0.00339	CcSEcCtD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—ABCB4—primary biliary cirrhosis	0.000628	0.00703	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000622	0.00335	CcSEcCtD
Dabigatran etexilate—Fatigue—Colchicine—primary biliary cirrhosis	0.000621	0.00335	CcSEcCtD
Dabigatran etexilate—UGT1A9—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000616	0.00689	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—primary biliary cirrhosis	0.000615	0.00688	CbGpPWpGaD
Dabigatran etexilate—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000605	0.00326	CcSEcCtD
Dabigatran etexilate—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000605	0.00326	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00059	0.00318	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00059	0.00318	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000589	0.00317	CcSEcCtD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	0.000584	0.00654	CbGpPWpGaD
Dabigatran etexilate—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00311	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00311	CcSEcCtD
Dabigatran etexilate—Urticaria—Colchicine—primary biliary cirrhosis	0.000572	0.00308	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00057	0.00307	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00057	0.00307	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00057	0.00307	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00301	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00301	CcSEcCtD
Dabigatran etexilate—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00301	CcSEcCtD
Dabigatran etexilate—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00301	CcSEcCtD
Dabigatran etexilate—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000554	0.00298	CcSEcCtD
Dabigatran etexilate—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000554	0.00298	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000531	0.00286	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000529	0.00285	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000529	0.00285	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CCL5—primary biliary cirrhosis	0.000521	0.00583	CbGpPWpGaD
Dabigatran etexilate—Asthenia—Colchicine—primary biliary cirrhosis	0.000517	0.00278	CcSEcCtD
Dabigatran etexilate—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000514	0.00277	CcSEcCtD
Dabigatran etexilate—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000514	0.00277	CcSEcCtD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—primary biliary cirrhosis	0.000513	0.00574	CbGpPWpGaD
Dabigatran etexilate—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00276	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00276	CcSEcCtD
Dabigatran etexilate—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000509	0.00569	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000493	0.00266	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—GGT1—primary biliary cirrhosis	0.000487	0.00545	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000484	0.00542	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00257	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00257	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—MMP9—primary biliary cirrhosis	0.000469	0.00525	CbGpPWpGaD
Dabigatran etexilate—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000464	0.0025	CcSEcCtD
Dabigatran etexilate—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000464	0.0025	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—NFKB1—primary biliary cirrhosis	0.000464	0.0052	CbGpPWpGaD
Dabigatran etexilate—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000463	0.00518	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Colchicine—primary biliary cirrhosis	0.000458	0.00247	CcSEcCtD
Dabigatran etexilate—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00247	CcSEcCtD
Dabigatran etexilate—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00247	CcSEcCtD
Dabigatran etexilate—Rash—Colchicine—primary biliary cirrhosis	0.000454	0.00245	CcSEcCtD
Dabigatran etexilate—Dermatitis—Colchicine—primary biliary cirrhosis	0.000454	0.00244	CcSEcCtD
Dabigatran etexilate—Headache—Colchicine—primary biliary cirrhosis	0.000451	0.00243	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000447	0.005	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000443	0.00239	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000443	0.00239	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—GGT1—primary biliary cirrhosis	0.00044	0.00493	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000428	0.00231	CcSEcCtD
Dabigatran etexilate—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000428	0.00231	CcSEcCtD
Dabigatran etexilate—Nausea—Colchicine—primary biliary cirrhosis	0.000428	0.00231	CcSEcCtD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—primary biliary cirrhosis	0.000424	0.00474	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000412	0.00222	CcSEcCtD
Dabigatran etexilate—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000412	0.00222	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IL4—primary biliary cirrhosis	0.000411	0.0046	CbGpPWpGaD
Dabigatran etexilate—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000408	0.0022	CcSEcCtD
Dabigatran etexilate—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000408	0.0022	CcSEcCtD
Dabigatran etexilate—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000408	0.0022	CcSEcCtD
Dabigatran etexilate—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000408	0.0022	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—GGT1—primary biliary cirrhosis	0.000406	0.00455	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000406	0.00454	CbGpPWpGaD
Dabigatran etexilate—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000406	0.00218	CcSEcCtD
Dabigatran etexilate—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000406	0.00218	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000405	0.00453	CbGpPWpGaD
Dabigatran etexilate—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00207	CcSEcCtD
Dabigatran etexilate—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00207	CcSEcCtD
Dabigatran etexilate—UGT2B7—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000379	0.00424	CbGpPWpGaD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—ALB—primary biliary cirrhosis	0.000376	0.00421	CbGpPWpGaD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—MMP9—primary biliary cirrhosis	0.000373	0.00417	CbGpPWpGaD
Dabigatran etexilate—ABCB1—liver—primary biliary cirrhosis	0.000364	0.00475	CbGeAlD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—primary biliary cirrhosis	0.000347	0.00388	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—LBR—primary biliary cirrhosis	0.000335	0.00375	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—ALB—primary biliary cirrhosis	0.000334	0.00374	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000329	0.00368	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000313	0.00351	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000308	0.00345	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000308	0.00344	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—CTGF—primary biliary cirrhosis	0.000301	0.00337	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.0003	0.00336	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—primary biliary cirrhosis	0.000295	0.0033	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000285	0.00319	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000282	0.00316	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—RAD51B—primary biliary cirrhosis	0.00028	0.00313	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000278	0.00312	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000277	0.0031	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000272	0.00305	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—ALB—primary biliary cirrhosis	0.000272	0.00305	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000272	0.00304	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PDE5A—primary biliary cirrhosis	0.00026	0.00291	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—primary biliary cirrhosis	0.000258	0.00289	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	0.000254	0.00284	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000253	0.00283	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000242	0.00271	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—OGDH—primary biliary cirrhosis	0.000242	0.00271	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—PPARGC1A—primary biliary cirrhosis	0.000229	0.00257	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000228	0.00255	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARGC1A—primary biliary cirrhosis	0.000224	0.00251	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—GGT1—primary biliary cirrhosis	0.000222	0.00248	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—ALB—primary biliary cirrhosis	0.000216	0.00242	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PDHX—primary biliary cirrhosis	0.000216	0.00242	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000211	0.00237	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000207	0.00232	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—NFKB1—primary biliary cirrhosis	0.000207	0.00231	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000205	0.0023	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—primary biliary cirrhosis	0.000203	0.00227	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—DLAT—primary biliary cirrhosis	0.000203	0.00227	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ABCB4—primary biliary cirrhosis	0.000203	0.00227	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—ACE2—primary biliary cirrhosis	0.000182	0.00204	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000182	0.00204	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—GGT1—primary biliary cirrhosis	0.00018	0.00202	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—AGT—primary biliary cirrhosis	0.000179	0.002	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000176	0.00197	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—primary biliary cirrhosis	0.000175	0.00196	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000175	0.00195	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000174	0.00195	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000169	0.00189	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	0.000164	0.00184	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000163	0.00183	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	0.000155	0.00173	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000154	0.00173	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LBR—primary biliary cirrhosis	0.000153	0.00171	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000152	0.0017	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000142	0.00159	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—REN—primary biliary cirrhosis	0.000138	0.00155	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000138	0.00154	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000129	0.00144	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000127	0.00142	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LBR—primary biliary cirrhosis	0.000124	0.00139	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.000124	0.00139	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000124	0.00138	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000122	0.00137	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NUP210—primary biliary cirrhosis	0.000122	0.00137	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000121	0.00136	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGFBP1—primary biliary cirrhosis	0.000121	0.00135	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	0.00012	0.00135	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000117	0.00131	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000117	0.00131	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ABCG2—primary biliary cirrhosis	0.000113	0.00127	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000113	0.00126	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—OGDH—primary biliary cirrhosis	0.00011	0.00124	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000108	0.00121	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000106	0.00119	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	0.000103	0.00116	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000103	0.00115	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000102	0.00114	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PDHX—primary biliary cirrhosis	9.84e-05	0.0011	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CTGF—primary biliary cirrhosis	9.73e-05	0.00109	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GOT2—primary biliary cirrhosis	9.65e-05	0.00108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	9.46e-05	0.00106	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL5—primary biliary cirrhosis	9.29e-05	0.00104	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DLAT—primary biliary cirrhosis	9.25e-05	0.00104	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCB4—primary biliary cirrhosis	9.25e-05	0.00104	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—OGDH—primary biliary cirrhosis	8.97e-05	0.001	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—ACE—primary biliary cirrhosis	8.63e-05	0.000966	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GOT1—primary biliary cirrhosis	8.33e-05	0.000932	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GGT1—primary biliary cirrhosis	8.33e-05	0.000932	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	8.19e-05	0.000916	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	8.09e-05	0.000905	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PDHX—primary biliary cirrhosis	7.99e-05	0.000895	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—AGT—primary biliary cirrhosis	7.77e-05	0.00087	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCB4—primary biliary cirrhosis	7.51e-05	0.000841	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DLAT—primary biliary cirrhosis	7.51e-05	0.000841	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARGC1A—primary biliary cirrhosis	7.41e-05	0.000829	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDH5—primary biliary cirrhosis	7.19e-05	0.000805	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR5—primary biliary cirrhosis	6.92e-05	0.000775	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	6.92e-05	0.000775	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—primary biliary cirrhosis	6.35e-05	0.00071	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL9—primary biliary cirrhosis	6.28e-05	0.000703	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	6.16e-05	0.000689	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	6.1e-05	0.000683	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ELMO1—primary biliary cirrhosis	5.81e-05	0.000651	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AGT—primary biliary cirrhosis	5.77e-05	0.000646	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LBR—primary biliary cirrhosis	5.69e-05	0.000637	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NUP210—primary biliary cirrhosis	5.56e-05	0.000622	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL10—primary biliary cirrhosis	5.54e-05	0.00062	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—AGT—primary biliary cirrhosis	5.47e-05	0.000612	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—ALB—primary biliary cirrhosis	5.33e-05	0.000597	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCL5—primary biliary cirrhosis	5.25e-05	0.000588	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCG2—primary biliary cirrhosis	5.17e-05	0.000578	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MMP3—primary biliary cirrhosis	5.05e-05	0.000566	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	5.04e-05	0.000565	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	4.84e-05	0.000541	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.8e-05	0.000537	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL5—primary biliary cirrhosis	4.77e-05	0.000534	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NUP210—primary biliary cirrhosis	4.52e-05	0.000506	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CTGF—primary biliary cirrhosis	4.43e-05	0.000496	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALB—primary biliary cirrhosis	4.43e-05	0.000496	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	4.42e-05	0.000495	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AGT—primary biliary cirrhosis	4.39e-05	0.000492	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GOT2—primary biliary cirrhosis	4.39e-05	0.000492	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP2—primary biliary cirrhosis	4.28e-05	0.00048	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCG2—primary biliary cirrhosis	4.2e-05	0.00047	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	4.11e-05	0.00046	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	4.11e-05	0.00046	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AGT—primary biliary cirrhosis	3.99e-05	0.000447	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GGT1—primary biliary cirrhosis	3.79e-05	0.000424	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GOT1—primary biliary cirrhosis	3.79e-05	0.000424	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.68e-05	0.000412	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	3.67e-05	0.00041	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CTGF—primary biliary cirrhosis	3.6e-05	0.000403	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GOT2—primary biliary cirrhosis	3.57e-05	0.0004	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	3.45e-05	0.000386	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	3.45e-05	0.000386	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARGC1A—primary biliary cirrhosis	3.37e-05	0.000378	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.27e-05	0.000366	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GGT1—primary biliary cirrhosis	3.08e-05	0.000345	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GOT1—primary biliary cirrhosis	3.08e-05	0.000345	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	3.07e-05	0.000344	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP3—primary biliary cirrhosis	2.98e-05	0.000334	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TYK2—primary biliary cirrhosis	2.98e-05	0.000334	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL5—primary biliary cirrhosis	2.82e-05	0.000315	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARGC1A—primary biliary cirrhosis	2.74e-05	0.000307	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.73e-05	0.000306	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AGT—primary biliary cirrhosis	2.63e-05	0.000294	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.37e-05	0.000265	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGT—primary biliary cirrhosis	2.36e-05	0.000264	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AGT—primary biliary cirrhosis	2.14e-05	0.000239	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CD80—primary biliary cirrhosis	2.09e-05	0.000234	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	2.07e-05	0.000232	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—primary biliary cirrhosis	2.02e-05	0.000226	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.93e-05	0.000216	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TYK2—primary biliary cirrhosis	1.76e-05	0.000197	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.65e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—primary biliary cirrhosis	1.64e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.64e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.61e-05	0.00018	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	1.41e-05	0.000158	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	1.41e-05	0.000158	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—primary biliary cirrhosis	1.39e-05	0.000155	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.37e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.26e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AGT—primary biliary cirrhosis	9.8e-06	0.00011	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—primary biliary cirrhosis	7.52e-06	8.42e-05	CbGpPWpGaD
